NCT06112197

Brief Summary

Study the correlation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jan 2024

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 26, 2023

Completed
6 days until next milestone

First Posted

Study publicly available on registry

November 1, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

January 5, 2024

Completed
1 year until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 5, 2025

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 5, 2025

Completed
Last Updated

November 2, 2023

Status Verified

October 1, 2023

Enrollment Period

1 year

First QC Date

October 26, 2023

Last Update Submit

October 31, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • correlation between METS IR and visceral fat in type 2 diabetes

    Study the cor relation between METS IR and visceral fat in type 2 diabetes and its relation to microvascular complication

    one year

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients of T2DM, either newly diagnosed or previously diagnosed and on treatment with antidiabetic oral hypoglycemic agents or insulin and attending diabetes OPD or admitted to the Medicine Department, were taken as cases. Age- and gender-matched nondiabetic people admitted to the Medicine Department were taken as control subjects. Both these groups will be interviewed, examined, investigated, and included in the study.

You may qualify if:

  • Age \> 18 years Both male and female subjects Subjects capable of giving consent and voluntarily willing to participate in the study

You may not qualify if:

  • Chronic kidney disease patients Any nondiabetic nephropathy patients Patients affected by hypertension Patients affected by ocular disorders Neuropathies of other etiologies like chronic liver disease patients, alcoholics, or drug addicts Critically ill patients of type 2 diabetes mellitus Patients who have not given consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mahmoud Soliman

Sohag, 00000, Egypt

Location

MeSH Terms

Conditions

Insulin Resistance

Condition Hierarchy (Ancestors)

HyperinsulinismGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Study Officials

  • mahmoud soliman

    Sohag University

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Ass.lecturer of internal medicine

Study Record Dates

First Submitted

October 26, 2023

First Posted

November 1, 2023

Study Start

January 5, 2024

Primary Completion

January 5, 2025

Study Completion

June 5, 2025

Last Updated

November 2, 2023

Record last verified: 2023-10

Locations